News & Events

KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer

KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer

Sotorasib, the Poster Child for Project Optimus: Truths and Fantasies

Sotorasib, the Poster Child for Project Optimus: Truths and Fantasies

Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health

Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health

Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer

Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer

Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC

Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Porter Details Future Directions For Treating Patients With KRAS G12C-Mutated NSCLC

Porter Details Future Directions For Treating Patients With KRAS G12C-Mutated NSCLC

CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research

CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research

Dr Mark Socinski on How Targeted Therapies Have Impacted Lung Cancer Outcomes

Dr Mark Socinski on How Targeted Therapies Have Impacted Lung Cancer Outcomes

Mirati, Amgen, Lilly and more race to the front line in KRAS-mutated NSCLC

Mirati, Amgen, Lilly and more race to the front line in KRAS-mutated NSCLC